• Case Processing & Reporting

    Individual Case Safety Reports (ICSR) in Pharmacovigilance

    The management of individual suspected adverse reactions and events is the basis of Pharmacovigilance and safety monitoring. We help you in the correct collection, processing, assessment, submission and follow-up of activities and reconciliations in all the following fields:

    Service Scope

    We offer the following case processing and safety reporting services:

    Pre-marketing (Clinical Trials) Complete management and assessment of SAE/SUSAR
    Post-Marketing Complete management and assessment of ICSR
    Safety Reporting Safety Reporting to CA

    Service Contents

    • Receipt and triage of ICSRs
    • Data entry
    • Medical assessment
    • MedDRA coding
    • Narrative production
    • Analysis of Similar Events (AOSE)
    • Quality control (QC)
    • CIOMS generation and distribution
    • Expedited and Periodic reports submission to CA
    • Reconciliation with external, internal data

    PV team strengths

    • Experts in ICSR processing

      Case processing is performed by qualified and highly trained pharmacovigilance staff following clear and comprehensive internal procedures for safety information management.

      Our experienced pharmacovigilance staffs are involved in case processing, reviewing MedDRA coding, and carrying out full quality control of each report.

    • Regulatory intelligence

      Managing regulatory intelligence is a key part of appropriate pharmacovigilance. Therefore, we keep abreast of any changes in the local regulations and update our core regulatory reporting requirements accordingly.

      Providing overall safety information management as per local regulatory requirements is our key services to client.

    • Timeline compliance

      Compliance with deadlines for expedited and aggregate reports is our top priority.

  • Safety Management Plan

    Safety Management Plan (SMP) Development

    Safety Management Plan (SMP) is one of the most important documents because it regulates all safety communication between the Sponsor and the Contract Research Organizations (CROs).

    Service Scope

    We offer the following SMP development services:

    Pre-Marketing (Clinical Trials) Safety Management Plan (SMP) development
    Post-Marketing Safety Management Plan (SMP) development
    Medical Device Safety Management Plan (SMP) development

    PV team strengths

    • Specialized in SMP development

      ADM PV team has various experiences in writing SMP and creating SMP documents for Clinical Trial, Post-Marketing and Medical Device.

    • Maintain high standard of SMP

      We work together with client to minimize compliance gaps and to improve efficiencies in managing your safety data.

  • Risk Management Plan

    Risk Management Plan (RMP) support for MFDS submissions

    RMP describes the risk management system and contains information regarding identified risks, potential risks and missing information. It outlines any risk minimization measures adopted and includes information about monitoring the effectiveness of these measures.

    Service Scope

    We offer the following Preparation of RMP services:

    RMP Development RMP Development
    • Safety Specification
    • Efficacy Specification
    • PV Monitoring Plan
    • Risk Minimization Plan
    RMP Amendment RMP Amendment

    Service Contents

    • Setting risk categories such as important identified risks, potential identified risks, and missing information
    • Summarizing and writing efficacy specification
    • Reviewing and outline routine and additional pharmacovigilance plan
    • Writing and development routine and additional risk minimization activities

    PV team strengths

    • Experts in RMP development

      ADM PV team has extensive experience in writing RMPs, setting risk categories, and assessing risk benefit analysis.

    • Identify evidence-based safety concerns

      We can help our clients determine important identified and potential risks for both detailed and abbreviated risk management plans.

  • Aggregate Reporting

    Safety reports need to be prepared according to the GVPs and local legislation requirements. These documents allow the MAHs to comply with the specific safety monitoring of their product.
    We are experts in safety reports and can support you in their preparation and monitoring.

    Service Scope

    We offer the following preparation of Periodic reporting services:

    Pre-marketing (Clinical Trials) DSUR: Development safety update report
    Post-marketing PBRER Periodic Benefit Risk Evaluation Report
    PSUR: Periodic safety update report
    RMP Implementation and Evaluation Report

    Service Contents

    • Developing and maintaining periodic reporting schedule
    • Drafting, medical reviewing, and formatting of reports
    • Responding to any requests that may be arisen from authority

    PV team strengths

    • Responding to any requests that may be arisen from authority

      ADM PV team is highly experienced in Periodic reports such as Periodic Safety Update Reports / Periodic Benefit Risk Evaluation Reports (PSURs/PBRERs) and RMP Implementation and Evaluation Reports in accordance with MFDS guidelines.

    • Maintain high quality of aggregate reporting

      Compliance with regulations and efficient safety information management based on discussions with clients.

  • Literature screening

    The scientific and medical literature is an important source of information for the safety profile of medicinal products, especially in the detection of new safety signals or emerging safety issues (ESI). We perform literature on a local and international level search.

    Service Scope

    We offer the following service:

    Literature screening Monthly updates for literature.

    PV team strengths

    • Specialized in literature screening

      Helping client to identify important signals through comprehensive and scientific literature screening.

  • Medical Devices Vigilance

    SMP Development & Adverse Incident Management

    Medical device vigilance is the collection, assessment, and reporting from the use of medical devices.

    Service Scope

    ADM PV team provides a full range of services for both device clinical trials and post-marketing medical devices needs.

    Safety Management Plan (SMP) development Safety Management Plan (SMP) development
    Case processing Complete management and assessment of ICSR
    Safety reporting to CA Safety Reporting to CA
    Literature screening Monthly updates for literature

    Service Contents

    • Safety Data Management
    • Adverse Device Effect (ADE) and Medical Device Incident (MDI) case processing, coding, and follow-up
    • Narrative production
    • Quality control (QC)
    • MedWatch creation and distribution
    • Device Vigilance Report preparation and submission to MFDS and NIDS
    • Literature search and review

    PV team strengths

    • Specialized in Medical Device Vigilance

      ADM PV team has experience in reporting Adverse Events related to medical device in MFDS and NIDS.

    • Processing Medical Device Vigilance

      We can help our clients comply with the regulations by carrying out Adverse Device Effects reporting tasks.

Pharmacovigilance

  • Case Processing
    & Safety Reporting
    Individual Case Safety Reports (ICSR) in Pharmacovigilance

    Expedited, Periodic reports
    submission to CA

    VIEW
  • Safety Management Plan
    (SMP)
    Safety Management Plan (SMP)
    Development

    SMP details the roles,
    responsibilities, processes, and
    timelines for all safety activities.

    VIEW
  • Risk Management Plan
    (RMP)
    Risk Management Plan (RMP)
    support for CA submissions

    RMP Development
    RMP amendment

    VIEW
  • Aggregate Reporting
    RMP Implementation and Evaluation Report Preparation

    PSUR/PBRER Preparation
    DSUR Development

    VIEW
  • Literature screening
    Searching literature on a local and international level
    VIEW
  • Medical Devices Vigilance
    SMP Development
    &
    Adverse Incident Management
    VIEW